153 results on '"Cavallari I"'
Search Results
2. Ischemic and bleeding risk by type 2 diabetes clusters in patients with acute coronary syndrome
3. Clopidogrel versus ticagrelor in high-bleeding risk patients presenting with acute coronary syndromes. insights from the multicenter START-ANTIPLATELET registry
4. Association between platelet reactivity and long-term bleeding complications following percutaneous coronary intervention in patients with and without diabetes
5. Terapie antitrombotiche in pazienti con infezione da SARS-CoV-2: Dalle attuali evidenze alle ragionevoli raccomandazioni – Position paper del gruppo di studio aterosclerosi, trombosi e biologia vascolare
6. P263 - The feasibility of MicroRNA-Based Approach in Prognostic Stratification in Bladder Cancer Patients
7. 2020P Circulating micro RNAs (cmiRNAs) as treatment outcome predictors in extensive small cell lung cancer (eSCLC) patients (pts) receiving atezolizumab plus carboplatin and etoposide (ACE): CATS/ML43257 study
8. Peripheral arterial disease has a strong impact on cardiovascular outcome in patients with acute coronary syndromes: from the START Antiplatelet registry
9. Non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and atrial thrombosis: An appraisal of current evidence Les NOAC chez les patients avec fibrillation atriale en cas de thrombose atriale: une révision des preuves actuelles
10. Effect of body mass index on ischemic and bleeding events in patients presenting with acute coronary syndromes: insights from the START-ANTIPLATELET registry
11. Ischemic and bleeding risk stratification in diabetic patients after acute coronary syndrome based on insulin requirement
12. 3054Efficacy and safety of non-vitamin K oral anticoagulants in patients with atrial fibrillation and cancer
13. Post-transcriptional Regulation of HTLV Gene Expression: Rex to the Rescue
14. Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs
15. Left atrial and auricular thrombosis in patients with atrial fibrillation: from pathophysiology to treatment
16. Thromboembolic Risk, Bleeding Outcomes and Effect of Different Antithrombotic Strategies in Very Elderly Patients With Atrial Fibrillation: A Sub‐Analysis From the PREFER in AF (PREvention oF Thromboembolic Events–European Registry in Atrial Fibrillation)
17. Chapter 'Urgent surgery early after percutaneous coronary intervention in a patient with atrial fibrillation on triple therapy of non-vitamin K antagonist oral anticoagulant, aspirin and clopidogrel' for the book 'Atrial fibrillation and percutaneous coronary intervention – A case-based guide to oral anticoagulation, antiplatelet therapy and stenting' (Editors A. Rubboli, G.Y.H. Lip) (Springer)
18. Insulin-Requiring Versus Noninsulin-Requiring Diabetes and Thromboembolic Risk in Patients With Atrial Fibrillation: PREFER in AF
19. P3837Net clinical benefit of NOACs vs. VKAs in elderly patients with atrial fibrillation: a pooled analysis from the real-world PREFER in AF and PREFER in AF PROLONGATION registries
20. Monacolin Product Monograph (Springer Healthcare)
21. P5153Net clinical benefit of oral anticoagulation in very elderly patients with atrial fibrillation: a sub-analysis from the PREFER in AF registry
22. Ezetimibe plus a Statin after Acute Coronary Syndromes
23. Prevention of post-operative atrial fibrillation by statin pre-treatment in patients undergoing cardiac surgery: a collaborative patient level meta-analysis of 11 randomized studies
24. Use of different spectroscopic tecniques in analysis of roman age wall paintings
25. Impact of the HTLV-1 p13II protein on cell growth and tumorigenesis
26. Functional analyses of the p13II protein of human T cell leucemia virus type I
27. Submitochondrial targeting and biochemical characterization of the p13II protein of HTLV-I
28. 421 Correction de la myopie forte : StickLens, résultats après 6 ans de recul
29. Differential expression of menin in sporadic pituitary adenomas.
30. Invasion of the Nest of Polistes dominulus by the Social Parasite Sulcopolistes sulcifer (Hymenoptera, Vespidae)1
31. Functional analysis of p13II, a mitochondrial protein coded by human T-cell leukemia virus type I (HTLV-I)
32. Functional analyses of P13II, a mitochondrial protein of human T-cell leukemia virus type-1
33. Functional analysis of the p13II protein of HTLV-1
34. The P13 Protein of HTLV-1 Modulates Mitochondrial K plus Permeability, Reactive Oxygen Species and Cell Death
35. Kinetics and intracellular compartmentalization of HTLV-1 gene expression
36. Analysis of temporal expression of HTLV-2 reveals similarities and functional differences from HTLV-1
37. Kinetics of human-T cell leukemia virus type 2 (HTLV-2) mRNA expression in PBMCs isolated from infected subjects
38. Temporal regulation of HTLV-2 expression in infected cell lines and patients: evidence for distinct expression kinetics with nuclear accumulation of APH-2 mRNA
39. Prevalence and clinical implications of eligibility criteria for prolonged dual antithrombotic therapy in patients with PEGASUS and COMPASS phenotypes: Insights from the START-ANTIPLATELET registry
40. Peripheral arterial disease has a strong impact on cardiovascular outcome in patients with acute coronary syndromes: from the START Antiplatelet registry
41. Questions and Answers on Practical Thrombotic Issues in SARS-CoV-2 Infection: A Guidance Document from the Italian Working Group on Atherosclerosis, Thrombosis and Vascular Biology
42. A Prospective Study to Evaluate the Effectiveness of Edoxaban for the Resolution of Left Atrial Thrombosis in Patients with Atrial Fibrillation
43. Differential expression of menin in sporadic pituitary adenomas
44. Interaction Between Diabetes Mellitus and Platelet Reactivity in Determining Long-Term Outcomes Following Percutaneous Coronary Intervention
45. Effect of Body Mass Index on Ischemic and Bleeding Events in Patients Presenting With Acute Coronary Syndromes (from the START-ANTIPLATELET Registry)
46. Vitamin D and Diabetes Mellitus
47. Impact of chronic kidney disease on platelet reactivity and outcomes of patients receiving clopidogrel and undergoing percutaneous coronary intervention
48. Rethinking weight loss treatments as cardiovascular medicine in obesity, a comprehensive review.
49. Integrating platelet reactivity in the age, creatinine and ejection fraction score to predict clinical outcomes following percutaneous coronary intervention in patients with chronic coronary syndrome: the PR-ACEF score.
50. Practical Guidance for the Use of SGLT2 Inhibitors in Heart Failure.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.